Paracetamol Accord (Paracetamol)

Paracetamol works by inhibiting cyclooxygenase enzymes in the central nervous system, which reduces the production of prostaglandins that mediate pain and fever. This central inhibition lowers the perception of pain and resets the hypothalamic temperature set‑point, providing analgesic and antipyretic effects.

The dose of Paracetamol Accord is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and severity of pain or fever. Healthcare providers follow local guidelines and consider liver and kidney function when selecting the appropriate dosage regimen.

Safety data for intravenous paracetamol in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks and may prefer alternative therapies unless the expected benefit justifies use. Consultation with a maternal‑fetal medicine specialist is recommended.

To order Paracetamol Accord, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Paracetamol Accord offers analgesic and antipyretic effects with a favorable safety profile compared with opioid‑based IV analgesics, which carry higher risks of respiratory depression and dependence. Unlike non‑steroidal anti‑inflammatory drugs, it has minimal impact on platelet function and gastric mucosa, making it suitable for patients where NSAIDs are contraindicated.

Paracetamol Accord must be stored at 2‑8 °C in a refrigerator. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the solution. Do not use the product if it has been exposed to temperatures outside the recommended range.

Paracetamol Accord is administered intravenously by a qualified healthcare professional. The solution is typically diluted in a compatible IV fluid and infused over a short period, usually 15 minutes, to achieve rapid analgesic and antipyretic effects. Administration guidelines are provided in the product’s prescribing information.

The most serious risks include severe allergic reactions such as anaphylaxis, life‑threatening skin disorders like Stevens‑Johnson syndrome, and acute liver injury, especially in cases of overdose or pre‑existing hepatic disease. Prompt recognition and medical intervention are essential if any of these reactions occur.

Paracetamol Accord should be avoided in patients with known hypersensitivity to paracetamol or any excipients in the formulation, those with severe hepatic impairment, and individuals who have experienced severe reactions to other paracetamol preparations. Caution is also advised for patients with significant renal dysfunction.